UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ________to _________
Commission file number 0-22874
JDS Uniphase Corporation
(Exact name of Registrant as Specified in its Charter)
|
Delaware
|
94-2579683
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(IRS Employer Identification Number)
|
163 Baypointe Parkway
San Jose, California 95134
(Address of Principal Executive Offices including Zip Code)
(408) 434-1800
(Registrant's Telephone Number, Including Area Code)
(Former name, former address and former fiscal year if changed
since last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file reports), and (2) has been subject to such filing
requirements for the past 90 days. YES [X] NO [ ]
Number of shares of Common Stock outstanding as of the latest practicable
date, January 31, 2000: 250,147,466. In addition, as of such
date, there were outstanding 105,973,567 Exchangeable Shares of JDS Uniphase
Canada Ltd. which are exchangeable at any time into Common Stock on a one-for-
one basis, entitle their holders to dividend and other rights economically
equivalent to those of the Common Stock, and through a voting trust, vote at
meetings of stockholders of the Registrant.
JDS Uniphase Corporation
FORM 10-Q
INDEX
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements (Unaudited):
Condensed Consolidated Statements of Operations
Three and Six months ended December 31, 1999 and 1998
Condensed Consolidated Balance Sheets
December 31, 1999 and June 30, 1999
Condensed Consolidated Statements of Cash Flows
Six months ended December 31, 1999 and 1998
Notes to Condensed Consolidated Financial
Statements
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of
Operations
Results of Operations
Operating Segment Information
Liquidity and Capital Resources
Current Status of Acquired In-process Research and Development Projects
Risks
ITEM 3. Quantitative and Qualitative Disclosure about Market Risks
PART II. OTHER INFORMATION
ITEM 1: Legal Proceedings
ITEM 2: Changes in Securities
ITEM 3: Defaults Upon Senior Securities
ITEM 4: Submission of Matters to a Vote of Security Holders
ITEM 5: Other Information
ITEM 6: Exhibits and Reports on Form 8-K
Signatures
PART I -- FINANCIAL INFORMATION
Item 1. Financial Statements
JDS Uniphase Corporation
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(In millions,)
Three Months Ended Six Months Ended
December 31, December 31,
------------------- -------------------
1999 1998 1999 1998
--------- --------- --------- ---------
Net sales................................ $281.7 $63.8 $511.8 $121.2
Cost of sales............................ 139.2 33.5 264.5 62.4
--------- --------- --------- ---------
Gross profit........................... 142.5 30.3 247.3 58.8
--------- --------- --------- ---------
Operating expenses:
Research and development............... 21.6 5.8 38.9 11.4
Selling, general and administrative.... 33.8 8.4 61.6 15.5
Amortization of purchased intangibles.. 185.1 4.0 358.0 7.9
Acquired in-process research and
development.......................... 19.7 -- 19.7 --
Other operating expenses............... -- 6.3 -- 6.3
--------- --------- --------- ---------
Total operating expenses................. 260.2 24.5 478.2 41.1
--------- --------- --------- ---------
Income (loss) from operations............ (117.7) 5.8 (230.9) 17.7
Interest and other income, net........... 10.7 0.8 16.2 1.8
--------- --------- --------- ---------
Income (loss) before income taxes...... (107.0) 6.6 (214.7) 19.5
Income tax expense....................... 24.2 4.2 30.5 8.9
--------- --------- --------- ---------
Net income (loss)........................ ($131.2) $2.4 ($245.2) $10.6
========= ========= ========= =========
Basic earnings (loss) per share.......... ($0.38) $0.02 ($0.72) $0.07
========= ========= ========= =========
Dilutive earnings (loss) per share....... ($0.38) $0.01 ($0.72) $0.06
========= ========= ========= =========
Weighted average common shares
Outstanding............................ 345.3 158.1 342.1 157.3
Dilutive effect of stock options
Outstanding............................ -- 10.9 -- 11.1
--------- --------- --------- ---------
Weighted average common shares
Outstanding, assuming dilution......... 345.3 169.0 342.1 168.4
========= ========= ========= =========
See accompanying notes.
JDS Uniphase Corporation
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except share and per share data)
December 31, June 30,
1999 1999
------------ ------------
(unaudited)
Assets
Current assets:
Cash and cash equivalents......................... 132.3 75.4
Short-term investments............................ 752.8 158.5
Accounts receivable, less allowances for returns
and doubtful accounts of $1.6 at December 31,
$1.1 at June 30,................................ 185.2 120.9
Inventories....................................... 134.7 87.9
Deferred income taxes............................. 12.5 7.9
Other current assets.............................. 10.8 13.0
------------ ------------
Total current assets........................... 1,228.3 463.6
Property, plant, and equipment, net.................. 256.5 181.1
Intangible assets, including goodwill................ 3,690.4 3,444.2
Long-term deferred income taxes and other assets..... 11.2 7.2
------------ ------------
Total assets................................... 5,186.4 4,096.1
============ ============
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable.................................. 70.0 38.1
Accrued payroll and related expenses.............. 43.9 27.2
Income taxes payable.............................. 27.7 37.2
Accrued expenses and other current liabilities.... 80.7 46.3
------------ ------------
Total current liabilities...................... 222.3 148.8
Deferred income taxes................................ 289.4 318.2
Accrued pension and other non-current liabilities.... 13.2 9.8
Commitments and contingencies
Stockholders' equity:
Preferred stock................................... -- --
Common stock and additional paid-in capital....... 5,110.5 3,822.8
Accumulated deficit............................... (443.0) (197.8)
Accumulated other comprehensive loss.............. (6.0) (5.7)
------------ ------------
Total stockholders' equity..................... 4,661.5 3,619.3
------------ ------------
Total liabilities and stockholders' equity..... 5,186.4 4,096.1
============ ============
See accompanying notes.
JDS Uniphase Corporation
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In millions)
Six Months Ended
December 31,
----------------------
1999 1998
---------- ----------
Operating activities
Net income (loss)..................................... ($245.2) $10.6
Adjustments to reconcile net income to net cash
provided by operating activities:
Acquired in-process research and development.......... 19.7 --
Depreciation and amortization expense............... 372.8 14.6
Deferred income taxes............................... (31.6) --
Write off of asset product line..................... -- 2.0
Change in operating assets and liabilities:
Accounts receivable.............................. (55.3) 2.0
Inventories...................................... (38.9) (5.6)
Other current assets............................. 2.8 --
Accounts payable, accrued liabilities and
other accrued expenses......................... 76.7 6.0
---------- ----------
Net cash provided by operating activities............... 101.0 29.6
---------- ----------
Investing activities
Purchase of short-term investments.................... (1,370.9) (153.4)
Proceeds from sale of short-term investments.......... 769.8 123.7
Acquisition of businesses............................. (131.9) (0.1)
Purchase of property, plant and equipment............. (76.4) (19.0)
Other investments..................................... (3.2) --
Decrease (increase) in other assets................... 0.4 (0.4)
---------- ----------
Net cash used in investing activities................... (812.2) (49.2)
---------- ----------
Financing activities
Proceeds from issuance of common stock and private
placement of exchangeable shares................ 713.5 --
Proceeds from issuance of common stock under
stock option and stock purchase plans........... 54.6 9.0
Pre-merger dividends paid on BCP stock................ -- (0.6)
---------- ----------
Net cash provided by financing activities............... 768.1 8.4
---------- ----------
Increase (decrease) in cash and cash equivalents........ 56.9 (11.2)
Cash and cash equivalents at beginning of period........ 75.4 40.5
---------- ----------
Cash and cash equivalents at end of period.............. $132.3 $29.3
========== ==========
SUPPLEMENTAL CASH FLOW INFORMATION
Tax benefits from stock option and stock
purchase plans.................................. $28.0 $8.2
See accompanying notes.
JDS Uniphase Corporation
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Business Activities and Basis of Presentation
The financial information at December 31, 1999 and for the three and six
month period ended December 31, 1999 and 1998 is unaudited, but includes all
adjustments (consisting only of normal recurring adjustments) that the Company
considers necessary for a fair presentation of the financial information set
forth herein, in accordance with generally accepted accounting principles for
interim financial information, the instructions to Form 10-Q and Article 10 of
Regulation S-X. Accordingly, such information does not include all of the
information and footnotes required by generally accepted accounting principles
for annual financial statements. For further information, refer to the
Consolidated Financial Statements and footnotes thereto included in the
Company's Annual Report on Form 10-K for the year ended June 30, 1999.
The results for the three and six month periods ended December 31, 1999
may not be indicative of results for the year ending June 30, 2000 or any future
period.
Fiscal Calendar Change
The Company will change its fiscal calendar effective
July 1, 2000. Fiscal periods thereafter will end on the Saturday nearest the
calendar month end. The change will not result in any differences in fiscal
2001 financial results as compared to the Company's current fiscal calendar.
Note 2. Comprehensive Income (loss)
The components of comprehensive income (loss), net of tax, are as
follows (in millions):
Three Months Ended Six Months Ended
December 31, December 31,
1999 1998 1999 1998
--------- --------- --------- ---------
Net income (loss)...................... ($131.2) $2.4 ($245.2) $10.6
Change in unrealized gain on
available-for-sale investments....... (2.2) 0.1 (1.9) 0.2
Change in foreign currency translation. (6.2) -- 1.6 3.5
--------- --------- --------- ---------
Comprehensive income................... ($139.6) $2.5 ($245.5) $14.3
========= ========= ========= =========
Note 3. Inventories
The components of inventory consist of the following (in millions):
December 31, June 30,
1999 1999
------------ ----------
Raw materials and purchased parts........... $55.6 $41.6
Work in process............................. 62.4 35.9
Finished goods.............................. 16.7 10.4
------------ ----------
$134.7 $87.9
============ ==========
Note 4. Earnings (loss) per Share
On July 8, 1999, the Company's Board of Directors approved a two-for-one
stock split of the common stock and the Exchangeable shares effective for
holders of record as of July 23, 1999. On September 28, 1999, the Board of
Directors approved a second two-for-one stock split of the common stock and
Exchangeable shares that became effective for holders of record as of December
22, 1999. All references to share and per-share data for all prior periods
presented have been restated to reflect these stock dividends and stock
splits.
As the Company incurred a loss for the three and six month periods ended
December 31, 1999, the effect of dilutive securities totaling 29.1 million and
27.0 million equivalent shares, respectively, has been excluded from the
computation as they are antidilutive.
Note 5. Stock Split
On January 3, 2000, the Board of Directors approved a two-for-one stock
split of all common stock and Exchangeable shares for holders of record as of
March 2, 2000. This split is subject to stockholder approval of an increase in
authorized capital to 3 billion shares from 600 million shares at a special
stockholders meeting scheduled for February 25, 2000.
Note 6. Income Tax Expense
The Company recorded a tax provision of $24.2 million in the second
quarter of 2000 as compared to $4.2 million in the same period of the prior
year. For the six months, the Company recorded a tax provision of $30.5 million
as compared to $8.5 million for the same period of the prior year. The tax
provision recorded in each quarter differs from the tax provision (benefit) that
otherwise would be calculated by applying the federal statutory rate to income
(loss) before income taxes primarily because of non-deductible acquisition-
related charges.
Note 7. Operating Segments
During the first quarter of fiscal 2000, JDS Uniphase changed the
structure of its internal organization following the merger that became
effective on the close of business June 30, 1999.
The President and Chief Operating Officer has been identified as the Chief
Operating Decision Maker as defined by SFAS 131. The President allocates
resources to each segment based on their business prospects, competitive
factors, net sales and operating profits before interest, taxes, and certain
purchase accounting related costs.
JDS Uniphase designs, develops, manufactures and markets optical components
and modules at various levels of integration. The Company views its business as
having two principal operating segments: Components and Modules. The
Components Group consists primarily of source lasers, pump lasers, external
modulator products, packaged lasers for fiber-based data communications,
couplers, filters, isolators, circulators, switches, attenuators, fiber Bragg
gratings, and connector products used primarily in telecommunications
applications. The Modules Group includes transmitters, amplifiers, transceivers,
and test instruments used in telecommunications and cable TV. The Company's
other operating segments, which are below the quantitative threshold defined by
SFAS 131, are disclosed in the "all other" category and consist of gas
laser based products for industrial, biotechnology and semiconductor equipment
applications, certain corporate-level operating expenses and the Ultrapointe
product line that was sold in 1999. All of the Company's products are sold
directly to original equipment manufacturers and industrial distributors
throughout the world.
Information on reportable segments is as follows (in millions):
Three Months Ended Six Months Ended
December 31, December 31,
------------------- -------------------
1999 1999 1999 1999
--------- --------- --------- ---------
Components:
Shipments.............................. $201.7 $36.9 $361.6 $71.3
Intersegment sales..................... (28.0) (0.7) (46.7) (1.6)
--------- --------- --------- ---------
Net sales to external customers........ $173.7 $36.2 $314.9 $69.7
Operating income....................... $66.9 $10.0 $121.8 $19.4
Modules:
Shipments.............................. $94.0 $12.8 $170.3 $22.0
Intersegment sales..................... -- -- -- --
--------- --------- --------- ---------
Net sales to external customers........ $94.0 $12.8 $170.3 $22.0
Operating income....................... $19.9 $3.7 $36.6 $5.5
Net sales by reportable segment........ $267.7 $49.0 $485.2 $91.7
All other net sales.................... 14.0 14.8 26.6 29.5
--------- --------- --------- ---------
$281.7 $63.8 $511.8 $121.2
========= ========= ========= =========
Operating income by reportable segments.. $86.8 $13.7 $158.4 $24.9
All other operating income (loss)........ 0.3 2.4 (11.6) 7.0
Unallocated amounts:
Acquisition related charges............ (204.8) (10.3) (377.7) (14.2)
Interest and other income, net......... 10.7 0.8 16.2 1.8
--------- --------- --------- ---------
Income (loss) before income taxes........ ($107.0) $6.6 ($214.7) $19.5
========= ========= ========= =========
Note 8. Acquisitions
Oprel Technologies Inc.
In December 1999, the Company acquired Oprel Technologies
Inc.("OPREL"), a developer of optical amplifiers, test equipment and
optoelectronic packaging, located in Nepean, Ontario. The transaction was
accounted for as a purchase and accordingly, the accompanying financial
statements include the results of operations of OPREL subsequent to the
acquisition date. The Company paid $9.3 million in cash and issued a total of
95,458 exchangeable shares of its subsidiary, JDS Uniphase Canada Ltd., each of
which is exchangeable for one share of common stock. The total purchase cost was
$27.7 million. The purchase price allocation is preliminary and included net
tangible assets of $1.4 million and intangible assets (including goodwill) of
$26.3 million that are expected to be amortized over a five-year period.
SIFAM Limited
In December 1999, the Company acquired SIFAM Limited ("SIFAM"),
a supplier of fused components for fiberoptic telecommunications networks which
is based in the United Kingdom. SIFAM products, which include couplers,
wavelength division multiplexers and gain flattening filters, are used for
advanced applications in optical amplifiers and network monitoring. The
transaction was accounted for as a purchase and accordingly, the accompanying
financial statements include the results of operations of SIFAM subsequent to
the acquisition date.
The preliminary allocation of the purchase price is as follows (in
millions):
Purchase price allocation:
Tangible net assets acquired....................... $4.3
Intangible assets acquired:
Developed technology.............................. 27.0
Trade secrets and patents......................... 6.1
Assembled workforce............................... 0.6
Goodwill.......................................... 56.6
In-process research and development................ 3.0
-----------
Total purchase price allocation................... $97.6
===========
The purchase price allocation is preliminary and is dependant upon the
Company's final analysis.
Tangible net assets acquired includes cash, accounts receivable,
inventories and fixed assets. Liabilities assumed principally include accounts
payable, accrued compensation and accrued expenses. Goodwill and intangible
assets acquired are each being amortized on a straight-line basis over estimated
useful lives ranging from three to five years.
A portion of the purchase price has been allocated to developed
technology and acquired in-process research and development ("IPRD").
Developed technology and IPRD were identified and valued through extensive
interviews, analysis of data provided by SIFAM concerning developmental
products, their stage of development, the time and resources needed to complete
them, if applicable, their expected income generating ability, target markets
and associated risks. The Income Approach, which includes an analysis of the
markets, cash flows, and risks associated with achieving such cash flows, was
the primary technique utilized in valuing the developed technology and IPRD.
Where development projects had reached technological feasibility, they
were classified as developed technology and the value assigned to developed
technology was capitalized. Where the development projects had not reached
technological feasibility and had no future alternative uses, they were
classified as IPRD and charged to expense upon closing of the transaction. The
Company estimates that a total investment of $0.3 million in research and
development over the next 15 months will be required to complete the IPRD. The
nature of the efforts required to develop the purchased IPRD into commercially
viable products principally relate to the completion of all planning, designing,
prototyping, verification and testing activities that are necessary to establish
that the products can be produced to meet their design specifications, including
functions, features and technical performance requirements.
In valuing the IPRD, the Company considered, among other factors, the
importance of each project to the overall development plan projected incremental
cash flows from the projects when completed and any associated risks. The
projected incremental cash flows were discounted back to their present value
using discount rates ranging from 14% to 22%. Discount rates were determined
after consideration of the Company's weighted average cost of capital and the
weighted average return on assets. Associated risks include the inherent
difficulties and uncertainties in completing each project and thereby achieving
technological feasibility, anticipated levels of market acceptance and
penetration, market growth rates and risks related to the impact of potential
changes in future target markets.
The acquired existing technology, which is comprised of products that are
already technologically feasible, includes products in the following areas:
fused couplers and attenuators, pump/signal wavelength division multiplexers,
polished products (polarizers, variable ratio couplers), and gain flattening
filters. The Company expects to amortize the acquired existing technology of
approximately $27.0 million on a straight-line basis over an average estimated
remaining useful life of 5 years.
The acquired core technology represents SIFAM trade secrets and patents
developed through years of experience designing and manufacturing fused
components for fiber optic telecommunication networks. This knowledge can be
leveraged by SIFAM to develop new and improved products and manufacturing
processes. The Company expects to amortize the acquired core technology of
approximately $6.1 million on a straight-line basis over an average estimated
remaining useful life of 5 years.
The acquired assembled workforce is comprised of approximately 50 skilled
employees across SIFAM's Sales and Marketing, Management, Supervision, Quality
& Training, General & Administrative, and Engineering groups. The
Company expects to amortize the value assigned to the assembled workforce of
approximately $0.6 million on a straight-line basis over an estimated remaining
useful life of 3 years.
Goodwill, which represents the excess of the purchase price of an investment
in an acquired business over the fair value of the underlying net identifiable
assets, is amortized on a straight-line basis over its estimated remaining
useful life of 5 years.
EPITAXX, INC.
In November 1999, the Company acquired EPITAXX,
Inc.("EPITAXX"), a supplier of optical detectors and receivers for
fiberoptic telecommunications and cable televisions networks. The transaction
was accounted for as a purchase and accordingly, the accompanying financial
statements include the results of operations of EPITAXX subsequent to the
acquisition date. The Company issued cash in the amount of $9.3 million and a
total of approximately 4.5 million shares of common stock in exchange for all of
the outstanding shares of EPITAXX common stock. Outstanding options to acquire
shares of EPITAXX common stock were converted into options to purchase shares of
the Company's common stock at the same exchange ratio.
The total purchase cost of EPITAXX is as follows (in millions):
Value of securities issued......................... $435.0
Assumption of options.............................. 61.9
-----------
Total Equity Consideration....................... 496.9
Cash paid to seller................................ 9.3
Direct transaction costs and expenses.............. 1.0
-----------
Total purchase cost................................ $507.2
===========
The preliminary allocation of the purchase price is as follows (in millions):
Purchase price allocation:
Tangible net assets acquired....................... $14.2
Intangible assets acquired:
Developed technology.............................. 63.4
Trademark and tradename........................... 5.4
Assembled workforce............................... 2.9
Goodwill.......................................... 403.4
In-process research and development................ 16.7
Deferred tax asset, net............................ 1.2
-----------
Total purchase price allocation................... $507.2
===========
The purchase price allocation is preliminary and is dependent upon the
Company's final analysis.
Tangible net assets acquired includes cash, accounts receivable,
inventories and fixed assets. Liabilities assumed principally include accounts
payable, accrued compensation accrued expenses, and Industrial Revenue Bonds.
Goodwill and intangible assets acquired are each being amortized on a straight-
line basis over estimated useful lives ranging from four to seven years.
A portion of the purchase price has been allocated to developed
technology and acquired in-process research and development ("IPRD").
Developed technology and IPRD were identified and valued through extensive
interviews, analysis of data provided by EPITAXX concerning developmental
products, their stage of development, the time and resources needed to complete
them, if applicable, their expected income generating ability, target markets
and associated risks. The Income Approach, which includes an analysis of the
markets, cash flows, and risks associated with achieving such cash flows, was
the primary technique utilized in valuing the developed technology and IPRD.
Where development projects had reached technological feasibility, they
were classified as developed technology and the value assigned to developed
technology was capitalized. Where the development projects had not reached
technological feasibility and had no future alternative uses, they were
classified as IPRD and charged to expense upon closing of the merger. The
Company estimates that a total investment of $0.8 million in research and
development over the next 13 months will be required to complete the IPRD. The
nature of the efforts required to develop the purchased IPRD into commercially
viable products principally relate to the completion of all planning, designing,
prototyping, verification and testing activities that are necessary to establish
that the products can be produced to meet their design specifications, including
functions, features and technical performance requirements.
In valuing the IPRD, the Company considered, among other factors, the
importance of each project to the overall development plan projected incremental
cash flows from the projects when completed and any associated risks. The
projected incremental cash flows were discounted back to their present value
using discount rates ranging from 12% to 18%. Discount rates were determined
after consideration of the Company's weighted average cost of capital and the
weighted average return on assets. Associated risks include the inherent
difficulties and uncertainties in completing each project and thereby achieving
technological feasibility, anticipated levels of market acceptance and
penetration, market growth rates and risks related to the impact of potential
changes in future target markets.
The acquired existing technology, which is comprised of products that are
already technologically feasible, includes products in the following areas: high
speed receivers for the telecommunications market, optical network monitoring,
and optical detectors/receivers for access/datacom applications and cable
television fiber optic networks. The Company expects to amortize the acquired
existing technology of approximately $63.4 million on a straight-line basis over
an average estimated remaining useful life of 7 years.
The trademarks and trade names include the EPITAXX trademark and trade name.
The Company expects to amortize the trademark and trade names of approximately
$5.4 million on a straight-line basis over an estimated remaining useful life of
7 years.
The acquired assembled workforce is comprised of approximately 400 skilled
employees across EPITAXX's Executive, Research and Development, Manufacturing,
Quality Assurance, Sales and Marketing, and General and Administrative groups.
The Company expects to amortize the value assigned to the assembled workforce of
approximately $2.9 million on a straight-line basis over an estimated remaining
useful life of 4 years.
Goodwill, which represents the excess of the purchase price of an investment
in an acquired business over the fair value of the underlying net identifiable
assets, is amortized on a straight-line basis over its estimated remaining
useful life of 7 years.
Ramar Corporation
In October 1999, the Company acquired Ramar Corporation ("Ramar")
of Northborough, Massachusetts for $1.0 million in cash and convertible debt as
described below, in a transaction accounted for as a purchase and accordingly,
the accompanying financial statements include the results of operations of Ramar
subsequent to the acquisition date. Ramar designs, develops and manufactures
lithium-niobate products for telecommunications applications. The convertible
debt is composed of $3.5 million in demand obligations and two performance-based
instruments totaling $1.0 million that become due upon achieving certain
milestones over the ensuing 12 to 24 months. The convertible debt bears interest
at 5.54% per annum and the principal can be exchanged for newly issued shares of
common stock at a price of $55.922 per share. The total purchase cost was $6.1
million. The purchase price allocation is preliminary and included net tangible
assets of $0.2 million and intangible assets (including goodwill) of $4.3
million (net of deferred tax) that are expected to be amortized over a five year
period. Convertible debt of $3.5 million is included in other current
liabilities.
Acquisition of AFC Technologies, Inc.
In August 1999, the Company acquired AFC Technologies, Inc. ("AFC")
of Ottawa, Canada for $22.0 million in cash and common stock of $17.5 million in
a transaction accounted for as a purchase and accordingly, the accompanying
financial statements include the results of operations of AFC subsequent to the
acquisition date. AFC designs, develops and manufactures fiber amplifiers for
telecommunications applications. The purchase price allocation included net
tangible assets of $1.3 million and intangible assets (including goodwill) of
$38.2 million that are expected to be amortized over a five-year period.
Note 10. Subsequent Events
On February 4, 2000, the Company completed its acquisition of Optical Coating
Laboratory, Inc. ("OCLI"), in a transaction accounted for as a
purchase, and OCLI now operates as a wholly-owned subsidiary of JDS Uniphase. As
consideration for the transaction, each outstanding share of OCLI common stock
was exchanged for 1.856 shares of JDS Uniphase common stock and outstanding
options to acquire OCLI common stock were converted into options to purchase the
Company's common stock at the same exchange ratio. The transaction is valued at
approximately $2.8 billion. The Company will record a charge for in-process
research and development in the quarter ended March 31, 2000 estimated at $84.1
million.
On January 17, 2000 the Company announced the signing of a definitive merger
agreement with E-TEK Dynamics, Inc. ("E-TEK") for approximately $15.5
billion in stock. The merger agreement provides for the exchange of 1.1 shares
of JDS Uniphase common stock for each common share of
E-TEK, subject to adjustment. E-TEK is a manufacturer of passive components
and modules for fiberoptic systems. Following completion of the merger, E-TEK
will operate as a wholly owned subsidiary of the Company. Completion of the
transaction is subject to customary closing conditions, including E-TEK
stockholder and regulatory approvals. This transaction will be accounted for as
a purchase with goodwill of approximately $14.6 billion which is expected to be
amortized over its estimated useful life of five years.
Concurrent with the signing of the merger agreement, the Company and E-TEK
signed a mutual supply agreement under which E-TEK is to supply certain products
to JDS Uniphase prior to completion of the merger.
Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations
Net Sales. For the quarter, net sales of $281.7 million represented
an increase of $217.9 million or 342% compared to the same period of the prior
year. For the six months, net sales were $511.8 million, an increase of $390.6
million or 322% compared to the same period of the prior year. The increase in
net sales reflected growth in each of our major operating segments and the
inclusion of JDS FITEL ("JDS") sales. We merged with JDS in a
transaction accounted for as a purchase which became effective at the close of
business on June 30, 1999. Separate discussions with respect to net sales and
operating profits for each of our reportable operating segments can be found
under the heading operating segment information.
Net sales for the three and six-month periods ended December 31, 1999 are
not considered indicative of the results to be expected for any future period.
In addition, there can be no assurance that the market for our products will
grow in future periods at its historical percentage rate or that certain market
segments will not decline. Further, there can be no assurance that we will be
able to increase or maintain our market share in the future or to achieve
historical growth rates.
Gross Profit. For the quarter, gross profit of $142.5 million
represented an increase of $112.2 million or 371% compared to the same period of
the prior year. For the six months, gross profit was $247.3 million, an
increase of $188.5 million or 321% compared to the same period of the prior
year. Strong demand for all our optical components and modules products combined
with the JDS merger contributed to the increases in gross profit. As a percent
of net sales, gross profit declined to 48% in the first six months of 2000 from
49% during the same period in 1999. The decline reflects the impact of an $11.6
million purchase accounting adjustment which increased JDS, EPITAXX and SIFAM
inventories. These adjustments flowed through to cost of sales during the first
six months.
There can be no assurance that we will be able to maintain gross profits
or gross margins at current levels in future periods. We expect that periodic
fluctuations in our gross margins will continue because of changes in our sales
and product mix, manufacturing constraints, competitive pricing pressures,
higher costs resulting from new production facilities, manufacturing yields,
acquisitions of businesses that may have different margins than ours and
inefficiencies associated with new product introductions.
Research and Development Expense. For the quarter, research and
development (R&D) expense of $21.6 million or 8% of net sales represented an
increase of $15.8 million or 274% compared to the same period of the prior year.
R&D expense for the six months was $38.9 million, an increase of $27.4
million or 240% compared to the same period of the prior year. The increase in
R&D expenses is primarily due to the continued development and enhancement
of our fiber optic product lines and the inclusion of JDS. As a percent of net
sales, R&D expense declined to 8% in the first six months from 9% during the
same period in 1999. Due to the rapidly growing business, it is difficult to
scale R&D programs at the same ratio as our sales growth.
We are committed to the continuation of making significant R&D
expenditures and expect that the absolute dollar amount of R&D expenses will
increase as we invest in developing new products and in expanding and enhancing
our existing product lines, although R&D expenses may vary as a percentage
of net sales in future periods. In addition, there can be no assurance that
expenditures for R&D will be successful or that improved processes or
commercial products will result from these projects.
Selling, General and Administrative Expense. For the quarter, selling,
general and administrative (SG&A) expense of $33.8 million or 12% of net
sales represented an increase of $25.4 million or 302% as compared to the same
period of the prior year. For the six months, SG&A expense was $61.6
million, an increase of $46.2 million or 298% compared to the same period of the
prior year. The increase is primarily due to higher SG&A costs to support
telecommunications products, and the inclusion of JDS. As a percentage of net
sales, SG&A remained between 12% and 13% during the first six months of both
2000 and 1999, respectively.
We expect the amount of SG&A expenses to increase in the future,
although such expenses may vary as a percentage of net sales in future periods.
We expect to continue incurring charges to operations, which to date have been
within management's expectations, associated with integrating Uniphase and JDS
operations. We may also incur costs associated with the integration of other
acquired operations.
Amortization of Purchased Intangibles. For the quarter, amortization
of purchased intangibles ("API") expense of $185.1 million or 66% of
net sales represented an increase of $181.1 million or 4,508% as compared to the
same period of the prior year. For the six months, API expense of $358.0
million, an increase of $350.1 million or 4,431% compared to the same period of
the prior year. The increase in API expense was primarily due to the intangible
assets recorded in connection with our merger in June 1999 with JDS in a
transaction accounted for as a purchase.
Our API expense will continue to generate net losses for the foreseeable
future. Goodwill and other intangibles arising from the JDS merger totaled $3.4
billion, including the related deferred tax effect. In addition, we have
recorded goodwill in connection with acquisitions of other business and will
record significant amounts of additional goodwill in connection with the
acquisition of OCLI and the pending E-TEK merger. API expense could change
because of other acquisitions or impairment of existing identified intangible
assets and goodwill in future periods.
Acquired In-process Research and Development. The Company recorded
$19.7 million or 4% of net sales of acquired in-process research and development
resulting from the acquisition of EPITAXX ($16.7 million) and SIFAM ($3.0
million). See Note 9 of Notes to Consolidated Financial Statements. These
amounts were expensed on the acquisition dates because the acquired technology
had not yet reached technological feasibility and had no future alternative
uses. There can be no assurance that acquisitions of businesses, products or
technologies by us in the future will not result in substantial charges for
acquired in-process research and development that may cause fluctuations in our
quarterly or annual operating results.
A description of the acquired in-process technologies, stage of development,
estimated completion costs, and time to complete at the date of the EPITAXX and
SIFAM acquisitions, as well as the current status of acquired in-process
research and development projects for each acquisition can be found at the end
of this Management's Discussion and Analysis of Financial Condition and Results
of Operations.
Interest and Other Income. For the quarter, net interest and other
income of $10.7 million or 3.8% of net sales represented an increase of $9.9
million or 1,172% as compared to the same period of the prior year. For the six
months, net interest and other income was $16.2 million, an increase of $14.4
million or 820% compared to the same period of the prior year. The increase in
interest and other income was the result of higher investment balances obtained
through cash generated from operating activities, our merger with JDS and the
completion of a public offering of our common stock and a private placement of
Exchangeable shares in August 1999 that generated $713.9 million in cash, net of
transaction costs.
Income Tax Expense. We recorded a tax provision of $24.2 million in
the second quarter of 2000 as compared to $4.2 million in the same period of the
prior year. For the six months, we recorded a tax provision of $30.5 million as
compared to $8.5 million for the same period of the prior year. The tax
provision recorded in each quarter differs from the tax provision (benefit) that
otherwise would be calculated by applying the federal statutory rate to income
(loss) before income taxes primarily due to non-deductible acquisition-related
charges.
Operating Segment Information
Components. For the quarter and six months, net sales of
components increased 379% and 352%, respectively, compared to the same period of
the prior year primarily because of the inclusion of JDS and increased demand
for active products used in optical communications applications. Operating
income increased 569% because of these same factors. Sales of components also
increased because of significantly higher use of our components in the modules
we build and contributions to net sales by SIFAM and EPITAXX during the second
quarter.
Modules. For the quarter and six months, net sales increased 636% and
673%, respectively, compared to the same period of the prior year primarily
because of the inclusion of JDS and increased demand for transmitters,
amplifiers and transceivers for CATV and telecommunications. Operating income
improved 441% because of these same factors.
Liquidity and Capital Resources
Our combined balance of cash, cash equivalents and short-term
investments was $885.1 million. During the period, we met our liquidity needs
through cash generated from operating activities. Net cash provided by operating
activities was $101.0 million, compared with $29.6 million for the same period
of the prior year.
Cash provided by operating activities was primarily generated from net
income before non-cash charges of $115.7 million. Higher levels of operating
activity resulted in increases in accounts receivable, inventories and other
liabilities using $17.5 million (net) of cash. Cash flow from operating
activities also benefited from a decrease in other current assets of $2.8
million.
During the first six months of 2000, cash used in investing activities
was $812.2 million compared with $49.2 million during the same period of the
prior year. The majority of this higher activity level was a result of
increased short term investments (net increase $601.1 million) following
completion of a public sale of our stock during the period. Acquisitions of
EPITAXX, SIFAM, OPREL, AFC Technologies and Ramar used $131.9 million in cash.
In addition, we incurred capital expenditures of $76.4 million for facility
expansions and equipment purchases to increase our manufacturing capacity
worldwide. We expect to continue to expand our worldwide manufacturing
capacity, primarily for telecommunications products, by making approximately
$110 million in additional capital expenditures during the remainder of the
year.
Cash of $768.1 million was generated from financing activities as
compared to $8.4 million in the same period of the prior year. The additional
cash was primarily attributable to our sale of common stock in a public offering
of common stock in August 1999. The exercise of stock options and the sale of
stock through our employee stock purchase plan generated $54.6 million in
cash.
We have an unsecured $10 million revolving line of credit. Advances under
the line of credit bear interest at the bank's prime rate (8.5% at December 31,
1999). There were no borrowings as of December 31, 1999. Under the terms of the
credit agreement, we are required to maintain certain minimum working capital,
net worth, profitability levels and other financial conditions. The agreement
also prohibits the payment of cash dividends and contains certain restrictions
on our ability to borrow money or purchase assets or interests in other entities
without the prior written consent of the bank. The line of credit expires in May
2000.
We believe that our existing cash balances and investments, together with
cash flow from operations and available lines of credit will be sufficient to
meet our liquidity and capital spending requirements at least through the end of
2000. However, possible investments in or acquisitions of complementary
businesses, products or technologies may require additional financing prior to
such time. There can be no assurance that additional debt or equity financing
will be available when required or, if available, can be secured on terms
satisfactory to us.
Current Status of Acquired In-Process Research and
Development Projects
We periodically review the stage of completion and likelihood of success of
each of the in-process research and development projects. The current status of
the in-process research and development projects for all major mergers and
acquisitions during the past three years are as follows:
SIFAM
PricewaterhouseCoopers LLP ("PwC") performed an allocation of the total
purchase price of SIFAM to its individual assets. Of the total purchase price,
$3.0 million has been allocated to in-process research and development and was
charged to expense in the quarter ended December 31, 1999. The remaining
purchase price has been allocated specifically to identifiable assets
acquired.
After allocating value to the in-process research and development projects
and SIFAM's tangible assets, specific intangible assets were then identified and
valued. The identifiable assets include existing technology, proprietary know-
how or core technology, and assembled workforce.
The in-process research and development is comprised of three main
categories: (1) miniature couplers; (2) combined components; and (3) micro-optic
devices. The following is a brief description of each acquired in-process
research and development project as of the date of the acquisition:
Miniature Couplers. SIFAM's current engineering efforts are focused
on reducing the coupler dimensions and building prototypes based on completed
feasibility studies. SIFAM expects the development cycle to continue for
approximately 3 months with completion scheduled by the end of the first quarter
in calendar year 2000. Development costs incurred on those products to date are
approximately $0.04 million with estimated cost to complete of approximately
$0.01 million, which SIFAM expects to incur ratably for the remainder of the
development cycle. SIFAM believes the associated risks of developing these
products to commercial viability include potential difficulties meeting customer
and market performance specifications and competition from products using
competing technologies that offer comparable functionality.
Combined Components. Current development efforts relate to
integration of various components into a single package. This will provide
customers with a single module that has multiple functionality previously
offered only in separate components. Integrated components also improve overall
system performance and reliability. SIFAM expects the development cycle to
continue for approximately 6 months with completion expected in the second
quarter of calendar year 2000. SIFAM believes the associated risks of
developing these products to commercial viability include potential difficulties
meeting customer and market performance specifications and competition from
products using competing technologies that offer comparable functionality.
Micro-optic Devices. Engineering effort in this area
encompasses development of other passive components used in optical
telecommunications networks. SIFAM expects the development cycle to continue
for approximately 15 months with completion expected in the second quarter of
calendar year 2001. Development costs incurred on those products to date are
approximately $0.06 million with estimated cost to complete of approximately
$0.14 million, which SIFAM expects to incur ratably for the remainder of the
development cycle. SIFAM believes the associated risks of developing these
products to commercial viability include potential difficulties meeting customer
and market performance specifications and competition from products using
competing technologies that offer comparable functionality.
Value Assigned To In-Process Research And Development
The value assigned to in-process research and development was determined by
considering the importance of each project to the overall development plan,
estimating costs to develop the purchased in-process research and development
into commercially viable products, estimating the resulting net cash flows from
the projects when completed and discounting the net cash flows to their present
value. The revenue estimates used to value the purchased in-process research
and development were based on estimates of relevant market sizes and growth
factors, expected trends in technology and the nature and expected timing of new
product introductions by SIFAM and its competitors.
The rates utilized to discount the net cash flows to their present value are
based on SIFAM's weighted average cost of capital. Given the nature of the
risks associated with the difficulties and uncertainties in completing each
project and thereby achieving technological feasibility, anticipated market
acceptance and penetration, market growth rates and risks related to the impact
of potential changes in future target markets, the weighted average cost of
capital was adjusted. Based on these factors, discount rates of 14% and 22%
were deemed appropriate for the existing and in-process technology,
respectively.
The estimates used in valuing in-process research and development were based
upon assumptions PwC believes to be reasonable but which are inherently
uncertain and unpredictable. PwC's assumptions may be incomplete or inaccurate,
and no assurance can be given that unanticipated events and circumstances will
not occur. Accordingly, actual results may vary from the projected results.
Any such variance may result in a material adverse effect on SIFAM's financial
condition and results of operations.
With respect to the acquired in-process technologies, the calculations of
value were adjusted to reflect the value creation efforts of SIFAM prior to the
acquisition. The range of estimated completion percentages and technology lives
are 25% to 75% and 5 years, respectively.
A portion of the purchase price has been allocated to developed technology
and acquired in-process research and development. Developed technology and in-
process research and development were identified and valued through extensive
interviews, analysis of data provided by SIFAM concerning developmental
products, their stage of development, the time and resources needed to complete
them, if applicable, their expected income generating ability, target markets
and associated risks. The Income Approach, which includes an analysis of the
markets, cash flows and risks associated with achieving such cash flows, was the
primary technique utilized in valuing the developed technology and in-process
research and development.
Where developmental projects had reached technological feasibility, they were
classified as developed technology, and the value assigned to developed
technology was capitalized. Where the developmental projects had not reached
technological feasibility and had no future alternative uses, they were
classified as in-process research and development and charged to expense upon
closing of the acquisition. SIFAM estimates that a total investment of
approximately $0.26 million in research and development over the next 15 months
will be required to complete the in-process research and development. The
nature of the efforts required to develop the purchased in-process research and
development into commercially viable products principally relate to the
completion of all planning, designing, prototyping, verification and testing
activities that are necessary to establish that the products can be produced to
meet their design specifications, including functions, features and technical
performance requirements.
EPITAXX, Inc.
PricewaterhouseCoopers LLP ("PwC") performed an allocation of the total
purchase price of EPITAXX to its individual assets. Of the total purchase
price, $16.7 million has been allocated to in-process research and development
and was charged to expense in the quarter ended December 31, 1999. The remaining
purchase price has been allocated to specifically identifiable assets
acquired.
After allocating value to the in-process research and development projects
and EPITAXX's tangible assets, specific intangible assets were then identified
and valued. The identifiable assets include existing technology, trademarks and
tradenames, and assembled workforce.
The in-process research and development relates to optical detectors and
receivers for long-haul terrestrial, submarine, and metro dense wavelength
division multiplexing ("DWDM") applications. The in-process research
and development is comprised of two main categories as mentioned above: (1) high
speed receivers, and (2) an optical spectrum analyzer product.
The following is a description of each acquired in-process research and
development project as of the date of the merger:
High Speed Receivers. Recently, the number of channels offered in
DWDM systems has grown from 4 to 160. This trend has simultaneously multiplied
the number of receivers used in the network, since receivers are used for each
channel at both sides of the fiber optic link as wavelength translation is
required. As channel and bit rates grow, increasing numbers of higher
performance receivers will be required. EPITAXX's current engineering efforts
are focused on developing both a K package and a coplanar package, as well as
development of highly integrated optical receiver products. The output of the K
package is easily accessible via a coax cable, while the output of the coplanar
device is via leads on the package which can be soldered directly onto a
receiver board, which simplifies large volume manufacturing. Integration of
electronic functions in both multi-chip modules and at the circuit board
subsystem level will allow EPITAXX to offer a complete optical receiver solution
to DWDM system level end users who may not posses microwave and digital design
resources. EPITAXX expects the development cycle to continue for approximately
6 and 12 months, with expected completion dates from the second through fourth
quarters of calendar year 2000. Development costs incurred on those products to
date are approximately $0.4 million with estimated cost to complete of
approximately $0.5 million which EPITAXX expects to incur ratably for the
remainder of the development cycle. EPITAXX believes the associated risks of
developing these products to commercial viability include potential difficulties
meeting customer and market performance specifications and competition from
products using competing technologies that offer comparable functionality.
Optical Spectrum Analyzer. This product has the ability to monitor
all wavelengths being used in a network and is an addition to the existing
product line related to network monitoring. Current development efforts relate
to the creation of a photodiode array, read-out integrated circuit, and optics
integration. EPITAXX expects the development cycle to continue for
approximately 13 months with completion expected in the fourth quarter of
calendar year 2000. Development costs incurred to date are approximately $0.15
million with estimated cost to complete of approximately $0.3 million which
EPITAXX expects to incur ratably for the remainder of the development cycle.
EPITAXX believes the associated risks of developing these products to commercial
viability include potential difficulties meeting customer and market performance
specifications and competition from products using competing technologies that
offer comparable functionality.
Value Assigned To In-Process Research And Development
The value assigned to in-process research and development was determined by
considering the importance of each project to the overall development plan,
estimating costs to develop the purchased in-process research and development
into commercially viable products, estimating the resulting net cash flows from
the projects when completed and discounting the net cash flows to their present
value. The revenue estimates used to value the purchased in-process research
and development were based on estimates of relevant market sizes and growth
factors, expected trends in technology and the nature and expected timing of new
product introductions by EPITAXX and its competitors.
The rates utilized to discount the net cash flows to their present value
are based on EPITAXX weighted average cost of capital. Given the nature of the
risks associated with the difficulties and uncertainties in completing each
project and thereby achieving technological feasibility, anticipated market
acceptance and penetration, market growth rates and risks related to the impact
of potential changes in future target markets, the weighted average cost of
capital was adjusted. Based on these factors, discount rates of 12 and 18% were
deemed appropriate for the existing and in-process technology, respectively.
The estimates used in valuing in-process research and development were
based upon assumptions PwC believes to be reasonable but which are inherently
uncertain and unpredictable. PwC's assumptions may be incomplete or inaccurate,
and no assurance can be given that unanticipated events and circumstances will
not occur. Accordingly, actual results may vary from the projected results.
Any such variance may result in a material adverse effect on EPITAXX's financial
condition and results of operations.
With respect to the acquired in-process technologies, the calculations of
value were adjusted to reflect the value creation efforts of EPITAXX prior to
the merger. The range of estimated completion percentages and technology lives
are 32% to 38% and 7 years, respectively.
The value assigned to each acquired in-process research and development
is as follows (in millions):
High Speed Receivers................................ $8.9
Optical Network Monitoring.......................... 7.8
-----------
Total acquired in-process research and development.. $16.7
===========
A portion of the purchase price has been allocated to developed technology
and acquired in-process research and development. Developed technology and in-
process research and development were identified and valued through extensive
interviews, analysis of data provided by EPITAXX concerning developmental
products, their stage of development, the time and resources needed to complete
them, if applicable, their expected income generating ability, target markets
and associated risks. The Income Approach, which includes an analysis of the
markets, cash flows and risks associated with achieving such cash flows, was the
primary technique utilized in valuing the developed technology and in-process
research and development.
Where developmental projects had reached technological feasibility, they
were classified as developed technology, and the value assigned to developed
technology was capitalized. Where the developmental projects had not reached
technological feasibility and had no future alternative uses, they were
classified as in-process research and development and charged to expense upon
closing of the merger. EPITAXX estimates that a total investment of
approximately $0.8 million in research and development over the next 13 months
will be required to complete the in-process research and development. The
nature of the efforts required to develop the purchased in-process research and
development into commercially viable products principally relate to the
completion of all planning, designing, prototyping, verification and testing
activities that are necessary to establish that the products can be produced to
meet their design specifications, including functions, features and technical
performance requirements.
JDS
The products under development at the time of our merger included: (i)
Thermo Optic Waveguide Attenuators, (ii) Solid State Switch, (iii) 50 GHz WDM,
and (iv) Erbium Doped Fiber Amplifiers ("EDFA"). Attenuator
development is expected to continue for approximately 12 months at a cost of
approximately $0.9 million ratably until its completion. Solid State Switch
development will continue for approximately six months at a cost of $1.4 million
incurred ratably over the period. WDM and EDFA developments are substantially
complete at a cost consistent with our expectations.
Uniphase Netherlands
The product introductions for the WDM lasers - CW and direct modulation and
DFB/EA and modulator are either on schedule or are approximately 6 months behind
schedule. The WDM laser - direct modulation is expected to have a lower revenue
growth rate than originally anticipated. The development of the semiconductor
optical amplifier technology has been delayed because of market demand for other
products. The development of the telecom technology is on schedule but the
revenue growth rate in initial periods is expected to be lower than originally
anticipated. Development of the CATV technologies is approximately 6 months
behind schedule and is expected to take a higher level of development effort to
achieve technological feasibility. We have incurred post-acquisition research
and development expenses of approximately $6.8 million in developing the
acquired in-process technology and estimate the cost to complete this
technology, in combination with our other continuing research and development
expenses, will not be in excess of our historic expenditures for research and
development as a percentage of our net sales. The differences between the actual
outcome noted above and the assumptions used in the original valuation of the
technology are not expected to significantly impact our results of operations
and financial position.
Uniphase Fiber Components
The initial products developed for submarine and unpackaged technology
projects were completed approximately on schedule and post-acquisition research
and development expenses approximately equaled the estimated cost to complete at
the acquisition date. The Company is experiencing higher levels of demand for
the submarine products than anticipated in the original estimates. The
temperature compensation project is behind schedule because of unforeseen
technical difficulties in maintaining specifications at the harshest
environmental test points, although we are satisfied with the developments
achieved to date. The dispersion compensation project is significantly behind
schedule and the market does not appear to be developing as anticipated. The
Add-Drop projects were discontinued concurrent with the merger with JDS. We have
incurred post-acquisition research and development expenses of approximately
$3.2 million in developing the acquired in-process technology and
estimate the cost to complete this technology, in combination with our other
continuing research and development expenses, will not be in excess of our
historic expenditures for research and development as a percentage of our net
sales. The differences between the actual outcome noted above and the
assumptions used in the original valuation of the technology are not expected to
significantly affect our results of operations and financial position.
Uniphase Laser Enterprise
The submount and RWG series products were released on schedule and post-
acquisition research and development expenses approximately equaled the
estimated cost to complete at the acquisition date. Actual revenue for
these products has significantly exceeded the estimates used in the valuation of
the technology. We did not pursue development of the distributed feedback laser
because of resources being redirected to expand the submount and RWG series
development program in response to strong market demand. The high power project
is somewhat delayed because of shifting R&D resources to submount/RWG
because of RWG demand. We have incurred post-acquisition research and
development expenses of approximately $7.2 million in developing the acquired
in-process technology and estimate the cost to complete this technology, in
combination with our other continuing research and development expenses, will
not be in excess of our historic expenditures for research and development as a
percentage of our net sales. The differences between the actual outcome noted
above and the assumptions used in the original valuation of the technology are
not expected to significantly impact our results of operations and financial
position
Item 3. Quantitative and Qualitative Disclosure About Market Risks
Foreign Exchange
We generate a significant portion of our sales from sales to
customers located outside the United States, principally in Europe.
International sales are made mostly from our foreign subsidiaries in the local
countries and are typically denominated in either U.S. dollars or the local
currency of each country. These subsidiaries also incur most of their expenses
in the local currency. Accordingly, all foreign subsidiaries use the local
currency as their functional currency.
Our international business is subject to risks typical of an
international business including, but not limited to differing economic
conditions, changes in political climate, differing tax structures, other
regulations and restrictions, and foreign exchange rate volatility. Accordingly,
our future results could be materially adversely affected by changes in these or
other factors.
We use forward foreign exchange contracts as the vehicle for hedging
certain assets and liabilities denominated in foreign currencies. In general,
these forward foreign exchange contracts have three months or less to maturity.
Gains and losses on hedges are recorded in non-operating other income as offset
against losses and gains on the underlying exposures. Management of the foreign
exchange hedging program is done in accordance with corporate policy.
At December 31, 1999, hedge positions totaled U.S. dollar $35.5 million
equivalent. All hedge positions are carried at fair value and all hedge
positions had maturity dates within three months.
Interest Rates
We invest our cash in a variety of financial instruments, including
floating rate bonds, municipal bonds, auction instruments and money market
instruments. These investments are denominated in U.S. dollars and Canadian
dollars. Cash balances in foreign currencies overseas are operating balances and
are only invested in short term deposits in local banks.
Investments in both fixed rate and floating rate interest earning
instruments carry a degree of interest rate risk. Fixed rate securities may have
their fair market value adversely affected by a rise in interest rates, while
floating rate securities may produce less income than expected if interest rates
fall. Due in part of these factors, the Company's future investment income may
fall short of expectations because of changes in interest rates or the Company
may suffer loses in principal if forced to sell securities which have seen a
decline in market value prior to their maturities because of changes in interest
rates.
Our investments are made in accordance with an investment policy
approved by the Board of Directors. No investment securities have maturities
exceeding three years, and the average duration of the portfolio does not exceed
eighteen months.
Forward-Looking Statements
Statements contained in this Quarterly Report on Form 10-Q which are not
historical facts are forward-looking statements within the meaning of Section
21E of the Securities Exchange Act of 1934, as amended. A forward-looking
statement may contain words such as "plans," "hopes,"
"believes," "estimates," "will continue to be,"
"will be," "continue to," "expect to,"
"anticipate that," " to be" or "can impact." These
forward-looking statements include statements relating to our expectations as to
(i) the timing of our proposed acquisition of E-TEK, (ii) the cost to complete
our acquired in-process research and development projects, the expected
amortization of such costs and the development cycles and timing of completion
of such projects, (iii) the amount (both in absolute dollars and as a percentage
of net sales) of our expenditures for research and development, selling, general
and administrative and capital acquisitions and improvements, (iv) the
sufficiency of existing cash balances and investments, together with cash flow
from operations and available lines of credit to meet our liquidity and capital
spending requirements at least through the end of the calendar year 2000, (v)
the development costs, anticipated completion, introduction and projected
revenues from new and developing products and technologies including the Thermo
Optic Waveguide Attenuator, Solid State Switch, WDM EDFA, WDM laser direct
modulation, the Submount and RWG series products and CATV technologies, and (vi)
costs associated with prior, pending and future acquisitions and plans relating
thereto. Management cautions that forward-looking statements are subject to
risks and uncertainties that could cause our actual results to differ materially
from those projected in such forward-looking statements. These risks and
uncertainties include the risk that (i) the proposed E-TEK acquisition will not
be completed, (ii) R&D expenditures will be materially greater or less than
those expected, (iii) funds will be insufficient to meet our liquidity and
capital resources requirements through the end of the calendar year 2000, (iv)
development costs, anticipated completion, introduction and projected revenues
from new and developing products and technologies may be materially different
than anticipated and (v) future acquisitions may not be completed as expected,
or at all. Further, our future business, financial condition and results of
operations are subject to risks and uncertainties including the risks set forth
below.
Risk Factors
JDS Uniphase Corporation is the result of a merger between Uniphase
Corporation and JDS pursuant to which they combined their operations on June 30,
1999. Historic information described in these Risk Factors pertains only to
either Uniphase Corporation or JDS. In such instances, historic information that
is specific to Uniphase Corporation or JDS is specifically described as
"Uniphase" or "JDS" information, respectively. References to
"we" and "us" refer to the combined entity resulting from
the merger of Uniphase and JDS.
Difficulties We May Encounter Managing Our Growth Could Adversely Affect
Our
Results of Operations
Both JDS and Uniphase have historically achieved their growth through a
combination of internally developed new products and acquisitions. As part of
our strategy to sustain growth, we expect to continue to pursue acquisitions of
other companies, technologies and complementary product lines. We also expect to
continue developing new components, modules and other products for our customer
base, seeking to further penetrate these markets. The success of each
acquisition will depend upon:
- our ability to manufacture and sell the products of the businesses
acquired,
- continued demand for these acquired products by our customers,
- our ability to integrate the acquired business' operations, products and
personnel,
- our ability to retain key personnel of the acquired businesses,
and
- our ability to expand our financial and management controls and reporting
systems and procedures.
Difficulties in Integrating Uniphase and JDS Could Adversely Affect Our
Business
We are the result of the combination on June 30, 1999 of Uniphase
Corporation and JDS. We are currently continuing our integration programs.
However, if JDS Uniphase fails to successfully integrate the businesses of JDS
and Uniphase, the combined business will suffer. Uniphase and JDS have
complementary business operations located principally in the United States,
Canada and Europe. Our success depends in large part on the successful
integration of these geographically diverse operations and the technologies and
personnel of the two companies. As part of this integration, we need to combine
and improve our computer systems to centralize and better automate processing of
its financial, sales and manufacturing data. Our management came from the prior
management teams of both companies and many members of management did not
previously work with other members of management. The integration of the two
businesses may result in unanticipated operations problems, expenses and
liabilities and the diversion of management attention. The integration may not
be successful, and, if so, our operating results would suffer as a result.
If We Fail to Efficiently Combine Uniphase's and JDS Sales and Marketing
Forces, Our Sales Could Suffer
We may experience disruption in sales and marketing in connection with
our efforts to integrate Uniphase's and JDS sales channels, and we may be unable
to efficiently or effectively correct such disruption or achieve our sales and
marketing objectives after integration. In addition, sales cycles and sales
models for Uniphase's and JDS various products may vary significantly from
product to product. Our sales personnel not accustomed to the different sales
cycles and approaches required for products newly added to their portfolio may
experience delays and difficulties in selling these newly added products.
Furthermore, it may be difficult to retain key sales personnel. As a result, we
may fail to take full advantage of the combined sales forces' efforts, and
Uniphase's and JDS respective sales approaches and distribution channels may be
ineffective in promoting the other entity's products, which may have a material
adverse effect on our business, financial condition or operating results.
Integration Costs and Expenses Associated with Uniphase's Combination with
JDS Have Been Substantial and We May Incur Additional Related Expenses in the
Future
JDS Uniphase has incurred direct costs associated with the combination of
approximately $12.0 million, which were included as a part of the total purchase
cost for accounting purposes. We may incur additional material charges in
subsequent quarters to reflect additional costs associated with the combination
which will be expensed as incurred.
Difficulties in Integrating Other Acquisitions Could Adversely Affect Our
Business
We have grown in large part through strategic acquisitions. Critical to the
success of such growth is the ordered, efficient integration of acquired
businesses into our organization. In March 1997, Uniphase acquired Uniphase
Laser Enterprise, which produces JDS Uniphase's 980-nanometer pump laser
products. In June 1998, Uniphase acquired Uniphase Netherlands. In the case of
both acquisitions, Uniphase acquired businesses that had previously been engaged
primarily in research and development and that needed to make the transition
from a research activity to a commercial business with sales and profit levels
that are consistent with our overall financial goals. This transition has not
yet been completed at Uniphase Netherlands, which continues to operate at higher
expense levels and lower gross margins than those required to meet our
profitability goals. In November 1998, Uniphase acquired Uniphase Broadband,
which manufactures test instruments, transmitter cards and transceivers for
telecommunications applications. In August 1999, we acquired AFC Technologies,
which products amplifiers for telecommunications applications. Also, in November
1999, we acquired EPITAXX, which supplies optical detectors and receivers for
fiber optic telecommunications and cable television networks. In December 1999,
we acquired SIFAM, a leading supplier of fused components for fiber optic
telecommunications networks which is based in the United Kingdom, and OPREL, a
developer of optical amplifiers, test equipment and optoelectronic packaging.
Also, in February 2000, we acquired OCLI, a leader manufacturer of optical thin
film coatings and components used to control and enhance light propagation to
achieve specific effects such as reflection, refraction, absorption and
wavelength separation. Finally, in January 2000, we signed a definitive
agreement to acquire E-TEK, a leader in the design and manufacturing of high
quality passive components and modules for fiberoptic systems. Each of these
acquisitions presents integration challenges, which we may fail to overcome. Any
failure of us to manage our growth and the integration challenges related to
that growth could materially harm its business, financial condition and
operating results.
Difficulties in Commercializing New Product Lines
We intend to continue to develop new product lines to address our
customers' diverse needs and the several market segments in which it
participates. As we target new product lines and markets, it will further
increase its sales and marketing, customer support and administrative functions
to support anticipated increased levels of operations from these new products
and markets as well as growth from its existing products. We may not be
successful in creating this infrastructure nor may we realize any increase in
the level of our sales and operations to offset the additional expenses
resulting from this increased infrastructure. In connection with our recent
acquisitions, we have incurred expenses in anticipation of developing and
selling new products. Our operations may not achieve levels sufficient to
justify the increased expense levels associated with these new businesses.
Any Failure of Our Information Technology Infrastructure Could Materially
Harm Our Results of Operations
Our success depends upon, among other things, the capacity, reliability
and security of our information technology hardware and software infrastructure.
Any failure relating to this infrastructure could significantly and adversely
impact our results of operations. In connection with our growth, we have
identified the need to update our current information technology infrastructure
and expect to incur significant costs to complete this upgrade. Currently, we
are (a) implementing a corporate-wide ERP system with integrated product data
management and manufacturing execution systems, (b) we are expanding and
enhancing our wide area network with higher bandwidth connections and redundant
links, and (c) integrating our voice communication systems. We must continue to
expand and adapt our system infrastructure to keep pace with our growth.
Demands on infrastructure that exceed our current forecasts could result in
technical difficulties. Upgrading the network infrastructure will require
substantial financial, operational and management resources, the expenditure of
which could affect the results of our operations. We may not successfully and
in a timely manner upgrade and maintain our information technology
infrastructure and a failure to do so could materially harm our business,
results of operations and financial condition.
We are Subject to Manufacturing Difficulties
If We Do Not Achieve Acceptable Manufacturing Volumes, Yields or
Sufficient Product Reliability, Our Operating Results Could Suffer
The manufacture of our products involves highly complex and precise
processes, requiring production in highly controlled and clean environments.
Changes in our manufacturing processes or those of our suppliers, or their
inadvertent use of defective or contaminated materials, could significantly
reduce our manufacturing yields and product reliability. Because the majority of
our manufacturing costs are relatively fixed, manufacturing yields are critical
to our results of operations. Certain of our divisions have in the past
experienced lower than expected production yields, which could delay product
shipments and impair gross margins. These divisions or any of our other
manufacturing facilities may not maintain acceptable yields in the future.
For example, our existing Uniphase Netherlands facility has not achieved
acceptable manufacturing yields since the June 1998 acquisition, and there is
continuing risk attendant to this facility and its manufacturing yields and
costs. Moreover, we recently completed construction of a new laser fabrication
facility at Uniphase Netherlands, and this facility has not yet reached targeted
yields, volumes or costs levels. Uniphase Netherlands may not successfully
manufacture laser products in the future at volumes, yields or cost levels
necessary to meet our customers' needs. To the extent we do not achieve
acceptable manufacturing yields or experience product shipment delays, our
business, operating results and financial condition would be materially and
adversely affected.
As our customers' needs for our products increase, we must increase our
manufacturing volumes to meet these needs and satisfy customer demand. Failure
to do so will have a material effect on our business, operating results and
financial condition. In some cases, existing manufacturing techniques, which
involve substantial manual labor, may be insufficient to achieve the volume or
cost targets of our customers. As such, we will need to develop new
manufacturing processes and techniques, which are anticipated to involve higher
levels of automation, to achieve the targeted volume and cost levels. In
addition, it is frequently difficult at a number of our manufacturing facilities
to hire qualified manufacturing personnel in a timely fashion, if at all, when
customer demands increase over shortened time periods. While we continue to
devote research and development efforts to improvement of our manufacturing
techniques and processes, we may not achieve manufacturing volumes and cost
levels in our manufacturing activities that will fully satisfy customer demands.
If we do not expand capacity rapidly enough, we will lose market share.
If Our Customers Do Not Qualify Our Manufacturing Lines For Volume Shipments,
Our Operating Results Could Suffer
Customers will not purchase any of our products (other than limited numbers
of evaluation units) prior to qualification of the manufacturing line for the
product. Each new manufacturing line must go through varying levels of
qualification with our customers. This qualification process determines whether
the manufacturing line achieves the customers' quality, performance and
reliability standards. Delays in qualification can cause a product to be dropped
from a long term supply program and result in significant lost revenue
opportunity over the term of that program. We may experience delays in obtaining
customer qualification of our new facility at Uniphase Netherlands. If we fail
in the timely qualification of these or other new manufacturing lines, our
operating results and customer relationships would be adversely affected.
Our Operating Results Suffer as a Result of Purchase Accounting Treatment,
Primarily due to the Impact of Amortization of Goodwill and Other Intangibles
Relating to Our Combination with JDS, the merger with OCLI and our Pending
Merger with E-TEK
Under U.S. generally accepted accounting principles that apply to us, we
accounted for a number of business combinations using the purchase method of
accounting, the most significant being the combination of Uniphase and JDS.
Under purchase accounting, we recorded the market value of our common shares and
the Exchangeable Shares issued in connection with Uniphase's combination with
JDS, the fair value of the options to purchase JDS common shares which became
options to purchase our common shares and the amount of direct transaction costs
as the cost of acquiring the business of JDS. That cost was allocated to the
individual assets acquired and liabilities assumed, including various
identifiable intangible assets such as in-process research and development,
acquired technology, acquired trademarks and trade names and acquired workforce,
based on their respective fair values. We allocated the excess of the purchase
cost over the fair value of the net assets to goodwill. We expensed in-process
research and development of $210.4 million as of June 30, 1999. Goodwill and
other intangible assets are being amortized over a five year period. The amount
of purchase cost allocated to goodwill and other intangibles was $3.4 billion,
including the related deferred tax effect. The amortization of goodwill and
other intangible assets in equal quarterly amounts over a five year period will
result in an accounting charge attributable to these items of $168 million per
quarter and $672 million per year. Additionally, in the second quarter of 2000
our gross profit was adversely impacted by $11.6 million due to purchase
accounting adjustments to products sold in the period. As a result, purchase
accounting treatment of Uniphase's combination with JDS will result in a net
loss for us in the foreseeable future, which could have a material and adverse
effect on the market value of our stock.
Additionally, as a result of the purchase accounting treatment of the
recent merger with OCLI and the pending merger with E-TEK, our earnings will
result in a net loss in the forseeable future which could have a material and
adverse effect on the market value of our stock.
Our Stock Price Could Fluctuate Substantially
The Unpredictability of Our Quarterly Operating Results Could Cause
Our Stock Price to be Volatile or Decline
We expect to continue to experience fluctuations in our quarterly
results, which in the future may be significant and cause substantial
fluctuations in the market price of our stock. All of the concerns we discuss
under Risk Factors could affect our operating results, including, among
others:
differ materially from those projected in the forward-looking statements.
- the timing of the receipt of product orders from a limited number of major
customers,
- the loss of one or more of our major suppliers or customers,
- competitive pricing pressures,
- the costs associated with the acquisition or disposition of
businesses,
- our ability to design, manufacture and ship technologically advanced
products with satisfactory yields on a timely and cost-effective
basis,
- the announcement and introduction of new products by us, and
- expenses associated with any intellectual property or other
litigation.
In addition to concerns potentially affecting our operating results addressed
elsewhere under Risk Factors, the following factors may also influence our
operating results:
- the relative proportion of our domestic and international sales,
- the timing differences between when we incur expenses to increase our
marketing and sales capabilities and when we realize benefits, if any, from such
expenditures, and
- fluctuations in the foreign currencies of our foreign operations.
Furthermore, our sales often reflect orders shipped in the same quarter that
they are received, which makes our sales vulnerable to short term fluctuations
in customer demand and difficult to predict. Also, customers may cancel or
reschedule shipments, and production difficulties could delay shipments. In
addition, we sell our telecommunications equipment products to OEMs who
typically order in large quantities, and therefore the timing of such sales may
significantly affect our quarterly results. An OEM supplies system level network
products to telecommunications carriers and others and incorporates our products
in these system level products. The timing of such OEM sales can be affected by
factors beyond our control, such as demand for the OEMs' products and
manufacturing risks experienced by OEMs. In this regard, we have experienced
rescheduling of orders by customers in each of our markets and may experience
similar rescheduling in the future. As a result of all of these factors, our
results from operations may vary significantly from quarter to quarter.
In addition to the effect of ongoing operations on quarterly results,
acquisitions or dispositions of businesses, our products or technologies have in
the past resulted in, and may in the future, result in reorganization of our
operations, substantial charges or other expenses, which have caused and may in
the future cause fluctuations in our quarterly operating results and cash flows.
See, for example, "Item 1. Business - Risk Factors - Our Operating Results May
Suffer as a Result of Purchase Accounting Treatment, the Impact of Amortization
of Goodwill and Other Intangibles Relating to Our Combination with JDS.''
Finally, our net revenues and operating results in future quarters may be
below the expectations of public market securities analysts and investors. In
such event, the price of our common stock and the Exchangeable Shares would
likely decline, perhaps substantially.
Factors Other Than Our Quarterly Results Could Cause Our Stock Price to be
Volatile or Decline
The market price of our common stock has been and is likely to continue
to be highly volatile because of causes other than our historical quarterly
results, such as:
- announcements by our competitors and customers of technological innovations
or new products,
- developments with respect to patents or proprietary rights,
- governmental regulatory action, and
- general market conditions.
In addition, the stock market has from time to time experienced significant
price and volume fluctuations that are unrelated to the operating performance of
particular companies, which may cause the price of our stock to decline.
Our Sales Would Suffer if One or More of Our Key Customers Substantially
Reduced Orders for Our Products
Our customer base is highly concentrated. Historically, orders from a
relatively limited number of OEM customers accounted for a substantial portion
of Uniphase's and JDS's net sales from telecommunications products. Two
customers, Lucent and Nortel, each accounted for over 10% of our net sales for
the quarter ended December 31, 1999. We expect that, for the foreseeable future,
sales to a limited number of customers will continue to account for a high
percentage of our net sales. Sales to any single customer may vary significantly
from quarter to quarter. If current customers do not continue to place orders we
may not be able to replace these orders with new orders from new customers. In
the telecommunications markets, our customers evaluate our products and
competitive products for deployment in their telecommunications systems. Our
failure to be selected by a customer for particular system projects can
significantly impact our business, operating results and financial condition.
Similarly, even if our customers select us, if our customers are not selected as
the primary supplier for an overall system installation, we can be similarly
adversely affected. Such fluctuations could have a material adverse effect on
our business, financial condition and operating results.
Interruptions Affecting Our Key Suppliers Could Disrupt Production,
Compromise Our Product Quality and Adversely Affect Our Sales
We currently obtain various components included in the manufacture of our
products from single or limited source suppliers. A disruption or loss of
supplies from these companies or a price increase for these components would
have a material adverse effect on our results of operations, product quality and
customer relationships. We have a sole source supply agreement for a critical
material used in the manufacture of our passive products. This agreement may be
terminated by either party on six months prior notice. It is our objective to
maintain strategic inventory of the key raw material provided by this supplier.
We have been dependent on OCLI as our sole source for filters for our WDM
products, and following the OCLI merger, we continue to be dependent on this
source for filters. In addition, we currently utilize a sole source for the
crystal semiconductor chip sets incorporated in our solid state microlaser
products and acquire our pump diodes for use in our solid state laser products
from Opto Power Corporation and GEC. We obtain lithium niobate wafers, gallium
arsenide wafers, specialized fiber components and certain lasers used in our
telecommunications products primarily from Crystal Technology, Inc., Fujikura,
Ltd., Philips Key Modules and Sumitomo, respectively. We do not have long-term
or volume purchase agreements with any of these suppliers (other than for our
passive products supplier described in this paragraph), and these components may
not in the future be available in the quantities required by us, if at all.
We May Become Subject to Collective Bargaining Agreements
Our employees who are employed at manufacturing facilities located in North
America are not bound by or party to any collective bargaining agreements with
us. These employees may become bound by or party to one or more collective
bargaining agreements with us in the future. Certain of our employees outside of
North America, particularly in The Netherlands and Germany, are subject to
collective bargaining agreements. If, in the future, any such employees become
bound by or party to any collective bargaining agreements, then our related
costs and our flexibility with respect to managing our business operations
involving such employees may be materially adversely affected.
Any Failure to Remain Competitive in Our Industry Would Impair Our
Operating Results
If Our Business Operations are Insufficient to Remain Competitive in
Our Industry, Our Operating Results Could Suffer
The telecommunications and laser subsystems markets in which we sell our
products are highly competitive. In each of the markets we serve, we face
intense competition from established competitors. Many of these competitors have
substantially greater financial, engineering, manufacturing, marketing, service
and support resources than do we and may have substantially greater name
recognition, manufacturing expertise and capability and longer standing customer
relationships than do we. To remain competitive, we believe we must maintain a
substantial investment in research and development, marketing, and customer
service and support. We may not compete successfully in all or some of our
markets in the future, and we may not have sufficient resources to continue to
make such investments, or we may not make the technological advances necessary
to maintain our competitive position so that our products will receive market
acceptance. In addition, technological changes or development efforts by our
competitors may render our products or technologies obsolete or uncompetitive.
Fiberoptic Component Average Selling Prices Are Declining
Prices for telecommunications fiberoptic components are generally declining
because of, among other things, increased competition and greater unit volumes
as telecommunications service providers continue to deploy fiberoptic networks.
Uniphase and JDS have in the past and we may in the future experience
substantial period to period fluctuations in average selling prices. We
anticipate that average selling prices will decrease in the future in response
to product introductions by competitors and us or to other factors, including
price pressures from significant customers. Therefore, we must continue to (1)
timely develop and introduce new products that incorporate features that can be
sold at higher selling prices and (2) reduce our manufacturing costs. Failure to
achieve any or all of the foregoing could cause our net sales and gross margins
to decline, which may have a material adverse effect on our business, financial
condition and operating results.
If We Fail to Attract and Retain Key Personnel, Our Business Could
Suffer
Our future depends, in part, on our ability to attract and retain certain key
personnel. In particular, our research and development efforts depend on hiring
and retaining qualified engineers. Competition for highly skilled engineers is
extremely intense, and we are currently experiencing difficulty in identifying
and hiring certain qualified engineers in many areas of our business. We may not
be able to hire and retain such personnel at compensation levels consistent with
our existing compensation and salary structure. Our future also depends on the
continued contributions of our executive officers and other key management and
technical personnel, each of whom would be difficult to replace. Continuing
uncertainty resulting from the JDS merger could further adversely affect our
ability to retain key employees. We do not maintain a key person life insurance
policy on our Chief Executive Officer, our Chief Operating Officer or any other
officer. The loss of the services of one or more of our executive officers or
key personnel or the inability to continue to attract qualified personnel could
delay product development cycles or otherwise have a material adverse effect on
our business, financial condition and operating results.
Market consolidation has created and continues to create companies that
are larger and have greater resources than us.
In the recent past, there have been a number of significant
acquisitions announced among our competitors and customers, including:
- Motorola, Inc./General Instruments Corporation;
- Cisco Systems, Inc., Cerent Corporation;
- Cisco Systems, Inc., Monterey Networks, Inc.;
- Corning Incorporated/Oak Industries, Inc.;
- Cisco Systems, Inc./Pirelli S.p.A;
- Nortel Networks Corp., Qtera Corp.; and
- Lucent Technologies, Inc., Ortel Corporation
The effect of these completed and pending acquisitions on us cannot be predicted
with accuracy, but some of these competitors are aligned with companies that are
larger or more well established than us. As a result, these competitors may have
access to greater financial, marketing and technical resources than us. Also,
consolidation of these and other companies may disrupt our marketing and sales
efforts.
Our Participation in International Markets Creates Risks to Our Business Not
Faced by Companies That Sell Their Products in the United States
International sales are subject to inherent risks, including:
- unexpected changes in regulatory requirements,
- tariffs and other trade barriers,
- political and economic instability in foreign markets,
- difficulties in staffing and management,
- integration of foreign operations,
- greater difficulty in accounts receivable collection,
- currency fluctuations, and
- potentially adverse tax consequences.
International sales accounted for approximately 40%, 38% and 32% of
Uniphase's net sales in 1999, 1998 and 1997, respectively. International sales
(excluding sales to the U.S.) accounted for approximately 21%, 25% and 20% of
JDS's net sales in 1999, 1998 and 1997, respectively. We expect that
international sales will continue to account for a significant portion of our
net sales. We may continue to expand our operations outside of the United States
and to enter additional international markets, both of which will require
significant management attention and financial resources.
Since a significant portion of our foreign sales are denominated in U.S.
dollars, our products may also become less price competitive in countries in
which local currencies decline in value relative to the U.S. dollar. Our
business and operating results may also be materially and adversely affected by
lower sales levels that typically occur during the summer months in Europe and
certain other overseas markets. Furthermore, the sales of many of our OEM
customers depend on international sales and consequently further exposes us to
the risks associated with such international sales.
The year 2000 problem may disrupt JDS Uniphase's and its customers' and
suppliers' businesses
Many currently installed computer systems and software products are
coded to accept only two digit entries in the date code field. As a result,
software that records only the last two digits of the calendar year may not be
able to distinguish whether "00" means 1900 or 2000. In addition, computer
programs may fail to recognize February 29, 2000 as a leap year date as a result
of an exception to the calculation of leap years that will occur in the year
2000 and otherwise occurs only once every 400 years. Residual Year 2000 problems
may result in miscalculations, data corruption, system failures or disruption of
operations. To date, we have not experienced any significant Year 2000 problems
in our internal technology systems or with the vendors of systems we believe to
be critical to our business. In addition, we believe that it is unlikely we will
experience any significant Year 2000 problems in the future.
However, our applications operate in complex network environments and
directly and indirectly interact with a number of other hardware and software
systems. We cannot predict whether Year 2000 unknown errors or defects that
affect the operation of software and systems that we use in operating our
businesses will arise in the future. If residual Year 2000 problems cause the
failure of any of the technology, software or systems necessary to operate our
business, We could lose customers, suffer significant disruptions in its
business, lose revenues and incur substantial liabilities and expenses. We
could also become involved in costly litigation resulting from Year 2000
problems. This could seriously harm our business, financial condition and
results of operations.
If We Have Insufficient Proprietary Rights or If We Fail to Protect Those
We Have, Our Business Would be Materially Impaired
We May Not Obtain the Intellectual Property Rights We Require
The telecommunications and laser markets in which we sell our products
experience frequent litigation regarding patent and other intellectual property
rights. Numerous patents in these industries are held by others, including
academic institutions and our competitors. In the past, Uniphase and JDS have
acquired and in the future we may seek to acquire license rights to these or
other patents or other intellectual property to the extent necessary for our
business. Unless we are able to obtain such licenses on commercially reasonable
terms, patents or other intellectual property held by others could inhibit our
development of new products for our markets. While in the past licenses
generally have been available to Uniphase and JDS where third-party technology
was necessary or useful for the development or production their products, in the
future licenses to third-party technology may not be available on commercially
reasonable terms, if at all. Generally, a license, if granted, includes payments
by us of up-front fees, ongoing royalties or a combination thereof. Such royalty
or other terms could have a significant adverse impact on our operating results.
We are a licensee of a number of third party technologies and intellectual
property rights and are required to pay royalties to these third party licensors
on certain of our telecommunications products and laser subsystems.
Our Products May Infringe the Property Rights of Others
The industry in which we operate experiences periodic claims of patent
infringement or other intellectual property rights. We have in the past and may
from time to time in the future receive notices from third parties claiming that
our products infringe upon third party proprietary rights. Any litigation to
determine the validity of any third-party claims, regardless of the merit of
these claims, could result in significant expense to us and divert the efforts
of our technical and management personnel, whether or not we are successful in
such litigation. If we are unsuccessful in any such litigation, we could be
required to expend significant resources to develop non-infringing technology or
to obtain licenses to the technology that is the subject of the litigation. We
may not be successful in such development or such licenses may not be available
on terms acceptable to us if at all. Without such a license, we could be
enjoined from future sales of the infringing product or products.
Our Intellectual Property Rights May Not Be Adequately Protected
Our future depends in part upon our intellectual property, including trade
secrets, know-how and continuing technological innovation. We currently hold
approximately 150 U.S. patents on products or processes and corresponding
foreign patents and have applications for certain patents currently pending. The
steps taken by us to protect our intellectual property may not adequately
prevent misappropriation or ensure that others will not develop competitive
technologies or products. Other companies may be investigating or developing
other technologies that are similar to ours. It is possible that patents may not
be issued from any application pending or filed by us and, if patents do issue,
the claims allowed may not be sufficiently broad to deter or prohibit others
from marketing similar products. Any patents issued to us may be challenged,
invalidated or circumvented. Further, the rights under our patents may not
provide a competitive advantage to us. In addition, the laws of certain
territories in which our products are or may be developed, manufactured or sold,
including Asia, Europe or Latin America, may not protect our products and
intellectual property rights to the same extent as the laws of the United
States.
If We Fail to Successfully Manage Our Exposure to the Worldwide Financial
Markets, Our Operating Results Could Suffer
We are exposed to financial market risks, including changes in interest
rates, foreign currency exchange rates and marketable equity security prices. We
utilize derivative financial instruments to mitigate these risks. We do not use
derivative financial instruments for speculative or trading purposes. The
primary objective of our investment activities is to preserve principal while at
the same time maximizing yields without significantly increasing risk. To
achieve this objective, a majority of our marketable investments are floating
rate and municipal bonds, auction instruments and money market instruments
denominated in U.S. dollars. We hedge currency risks of investments denominated
in foreign currencies with forward currency contracts. Gains and losses on these
foreign currency investments are generally offset by corresponding gains and
losses on the related hedging instruments, resulting in negligible net exposure
to us. A substantial portion of our revenue, expense and capital purchasing
activities are transacted in U.S. dollars. However, we do enter into these
transactions in other currencies, primarily Canadian and European currencies. To
protect against reductions in value and the volatility of future cash flows
caused by changes in foreign exchange rates, we have established hedging
programs. Currency forward contracts are utilized in these hedging programs. Our
hedging programs reduce, but do not always entirely eliminate, the impact of
foreign currency exchange rate movements. Actual results on our financial
position may differ materially.
If We Fail to Obtain Additional Capital at the Times, in the Amounts and
Upon the Terms Required, Our Business Could Suffer
We are devoting substantial resources for new facilities and equipment to
the production of source lasers, fiber Bragg gratings and modules used in
telecommunications and for the development of new solid state lasers. Although
we believe existing cash balances, cash flow from operations, available lines of
credit and the proceeds from the recently completed public offering of our
common stock and the private placement of Exchangeable shares in Canada will be
sufficient to meet our capital requirements at least for the next 12 months, we
may be required to seek additional equity or debt financing to compete
effectively in these markets. We cannot precisely determine the timing and
amount of such capital requirements and will depend on several factors,
including our acquisitions and the demand for our products and products under
development. Such additional financing may not be available when needed, or, if
available, may not be on terms satisfactory to us.
Our Currently Outstanding Preferred Stock and Our Ability to Issue
Additional Preferred Stock Could Impair the Rights of Our Common
Stockholders
Our Board of Directors has the authority to issue up to 799,999 shares of
undesignated preferred stock and to determine the powers, preferences and rights
and the qualifications, limitations or restrictions granted to or imposed upon
any wholly unissued shares of undesignated preferred stock and to fix the number
of shares constituting any series and the designation of such series, without
the consent of our stockholders. The preferred stock could be issued with
voting, liquidation, dividend and other rights superior to those of the holders
of common stock. The issuance of preferred stock under certain circumstances
could have the effect of delaying, deferring or preventing a change in control.
Each outstanding share of our common stock includes one right. Each right
entitles the registered holder, subject to the terms of the Rights Agreement, to
purchase from us one unit, equal to one one-thousandth of a share of Series B
Preferred Stock, at a purchase price of $600 per unit, subject to adjustment,
for each share of common stock held by the holder. The rights are attached to
all certificates representing outstanding shares of our common stock, and no
separate rights certificates have been distributed. The purchase price is
payable in cash or by certified or bank check or money order payable to our
order. The description and terms of the rights are set forth in a Rights
Agreement between us and American Stock Transfer & Trust Company, as Rights
Agent, dated as of June 22, 1998, as amended from time to time.
Certain provisions contained in the rights plan, and in the equivalent rights
plan our subsidiary, JDS Uniphase Canada Ltd., has adopted with respect to its
exchangeable shares ("Exchangeable Shares"), may have the effect of
discouraging a third party from making an acquisition proposal for us and may
thereby inhibit a change in control. For example, such provisions may deter
tender offers for shares of common stock or Exchangeable Shares which offers may
be attractive to the stockholders, or deter purchases of large blocks of common
stock or Exchangeable Shares, thereby limiting the opportunity for stockholders
to receive a premium for their shares of common stock or Exchangeable Shares
over the then-prevailing market prices.
Certain Anti-Takeover Provisions Contained in Our Charter and Under Delaware
Law Could Impair a Takeover Attempt
We are subject to the provisions of Section 203 of the Delaware General
Corporation Law prohibiting, under certain circumstances, publicly-held Delaware
corporations from engaging in business combinations with certain stockholders
for a specified period of time without the approval of the holders of
substantially all of its outstanding voting stock. Such provisions could delay
or impede the removal of incumbent directors and could make more difficult a
merger, tender offer or proxy contest involving us, even if such events could be
beneficial, in the short term, to the interests of the stockholders. In
addition, such provisions could limit the price that certain investors might be
willing to pay in the future for shares of our common stock. Our Certificate of
Incorporation and Bylaws contain provisions relating to the limitations of
liability and indemnification of our directors and officers, dividing our Board
of Directors into three classes of directors serving three-year terms and
providing that our stockholders can take action only at a duly called annual or
special meeting of stockholders. These provisions also may have the effect of
deterring hostile takeovers or delaying changes in control or management of
us.
PART II--OTHER INFORMATION
Item 1. Legal Proceedings
Reference is made to Item 3. Legal Proceedings, in the Registrant's
Annual Report on Form 10-K for the year ended June 30, 1999 and Part II, Item
1.
Item 2. Changes in Securities
In October 1999, the Company acquired Ramar Corporation for $1.0
million in cash and $3.5 million of convertible debt. Such convertible debt was
issued pursuant to an exemption from registration under Section 4(2) of the
Securities Act of 1933, as amended. The convertible debt is composed of $2.5
million of aggregated demand obligations and two performance-based instruments
totaling $1.0 million that become due upon achieving certain milestones over the
ensuing 12 months. The convertible debt bears interest at 5.59% and the
principal can be exchanged for newly issued shares of JDS Uniphase common stock
at a price of $55.922 per share. The convertible debt is unsecured .
In November 1999, the Company acquired EPITAXX, Inc. for $9.3 million in cash
and 4.5 million shares of our common stock valued at approximately $497.7
million. The issuance of the common stock was exempt from registration pursuant
to Section 4(2) of the Securities Act of 1933, as amended. The stock was issued
to former shareholders of EPITAXX.
In December 1999, the Company amended its Certificate of Incorporation to
increase the number of authorized shares of Common Stock from 300,000,000 shares
to 600,000,000.
In December 1999, the Company acquired Oprel Technologies, Inc. for $9.4
million in cash and 95,458 exchangeable shares of its subsidiary, JDS Uniphase
Canada Ltd., each of which is exchangeable at the option of the holder for one
share of common stock. The total value of the securities issued was $18.3
million. The issuance of the exchangeable shares was exempt from registration
pursuant to Regulation S promulgated under the Securities Act of 1933, as
amended. The stock was issued to former stockholders of Oprel Technologies,
Inc.
In December 1999, the Company issued 10,892 shares of common stock in
exchange for $0.3 million of convertible debt issued in connection with its
purchase in 1998 of certain assets from Chassis Engineering, Inc.
Item 3. Defaults upon Senior Securities
None
Item 4. Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders (the "Annual Meeting")
of the Company was held on December 16, 1999.
At the Annual Meeting, three items were put to a vote of the
stockholders:
- The election of the following four Class III directors of the Company to
serve until the 2002 Annual Meeting of Stockholders, and until their successors
are elected and qualified: Kevin Kalkhoven, Dr. Jozef Straus, Cazimir Skrzypczak
and Bruce Day. The following directors continued as members of the Company's
Board: William J. Sinclair, Peter Guglielmi, Robert E. Enos, Martin Kaplan, John
A. MacNaughton and Wilson Sibbett, Ph.D.
- An amendment to increase the aggregate number of shares of common stock
which the Company is authorized to issue from 300,000,000 to 600,000,000
shares.
- The appointment of Ernst & Young LLP as the independent auditors for the
Company for the fiscal year ending June 30, 2000.
The voting results were:
Item For Against Abstained
------------------------------ ------------ ------------ ------------
1. Directors
Kevin Kalkhoven................137,953,506 128,662
Dr. Jozef Straus...............137,953,506 128,662
Cazimir Skrzypczak.............137,953,506 128,662
Bruce Day......................137,953,506 128,662
2. Increase in authorized
share capital................137,353,553 50,785 128,662
3. Appointment of auditors........137,953,506 212,604 128,662
Item 5. Other Information
None
Item 6. Exhibits and Reports on Form 8-K
Exhibits
3.1(1) Amended and Restated Certificate of Incorporation.
3.2(2) Certificate of Amendment to Amended and Restated Certificate of
Incorporation.
3.3(3) Certificate of Amendment to Amended and Restated Certificate of
Incorporation.
3.4(4) Certificate of Amendment to Amended and Restated Certificate of
Incorporation.
3.5(4) Certificate of Designation.
3.6(2) Certificate of Designation.
3.7(5) Certificate of Designation.
3.8 Certificate of Amendment to Amended and Restated Certificate of
Incorporation.
3.9 Certificate of Amendment to Amended and Restated Certificate of
Incorporation.
10.1 Agreement and Plan of Merger by and among JDS Uniphase
Corporation, JDS Uniphase Acquisition, Inc., EPITAXX, Inc.
and the stockholders of EPITAXX, Inc., dated a of October 1,
1999.
27.1 Financial Data Schedule.
99.1 Security Ownership of Certain Beneficial Owners and Management
___________________________
(1) Incorporated by reference to the exhibits filed with the Registrant's
registration statement on Form S-1, which was declared effective November 17,
1993.
(2) Incorporated by reference to the exhibit to the Company's Registration
Statement on Form S-3 filed July 14, 1999.
(3) Incorporated by reference to the exhibit to the Company's Report on Form 10-
Q for the period ending December 31, 1998.
(4) Incorporated by reference to the exhibit to the Company's Report of Form 10-
K filed September 28, 1998.
(5) Incorporated by reference to the exhibit to the Company's current Report on
Form 8-K filed June 24, 1998.
b) Reports on Form 8-K
Report on Form 8-K as filed on October 4, 1999.
Report on Form 8-K/A as filed on November 3, 1999.
Report on Form 8-K as filed on November 5, 1999.
Report on Form 8-K/A as filed on November 30, 1999.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
JDS Uniphase Corporation
------------------------------------------
(Registrant)
Date: February 10, 2000 /s/ Anthony R. Muller
------------------------------------------
Anthony R. Muller, Senior Vice President and CFO
(Principal Financial and Accounting Officer)
Date: February 10, 2000 /s/ Kevin N. Kalkhoven
------------------------------------------
Kevin N. Kalkhoven, Chairman and CEO
(Principal Executive Officer)
